Ju Mingyi, Tong Weiwei, Bi Jia, Zeng Xianxin, Qi Aoshuang, Sun Mingli, Wen Jian, Zhao Lin, Wei Minjie
Department of Pharmacology, School of Pharmacy, China Medical University, Shenyang, 110122, China.
Liaoning Key Laboratory of molecular targeted anti-tumor drug development and evaluation, China Medical University, Shenyang, 110122, China.
Adv Sci (Weinh). 2025 Feb;12(8):e2413607. doi: 10.1002/advs.202413607. Epub 2025 Jan 4.
Hydrogen sulfide (HS)-mediated protein S-sulfhydration has been shown to play critical roles in several diseases. Tumor-associated macrophages (TAMs) are the predominant population of immune cells present within solid tumor tissues, and they function to restrict antitumor immunity. However, no previous study has investigated the role of protein S-sulfhydration in TAM reprogramming in breast cancer (BC). Therefore, the aim is to investigate whether protein S-sulfhydration can regulate TAM reprogramming and its underlying mechanism in BC. The results showed that in BC, the CTH-HS axis is positively correlated with the presence of an anti-tumor phenotype in TAMs. NaHS, as an HS donor, repolarized TAMs into M1 macrophages to block the tumor-promoting activities of TAMs both in vitro and in vivo. Mechanistically, HS-mediated S-sulfhydration of the protein chaperone glucose-regulated-protein 78 (GRP78) induced endoplasmic reticulum transmembrane protein kinase-1α (IRE-1α) dissociation from GRP78, which enhanced the phosphatase activity of IRE-1α itself in BC-TAMs, while the Cys420 site mutation of GRP78 interfered with these effects. Collectively, GRP78 S-sulfhydrylation mediated by HS at the Cys420 residue decreased the tumor burden and inhibited lung metastasis of BC through reprograming TAMs via activating the IRE-1α pathway, indicating that targeting GRP78 S-sulfhydration represents a promising intervention for TAM-M1 repolarization in BC.
硫化氢(HS)介导的蛋白质S-硫巯基化已被证明在多种疾病中起关键作用。肿瘤相关巨噬细胞(TAM)是实体瘤组织中存在的主要免疫细胞群体,其功能是限制抗肿瘤免疫。然而,以前没有研究调查过蛋白质S-硫巯基化在乳腺癌(BC)中TAM重编程中的作用。因此,目的是研究蛋白质S-硫巯基化是否能调节BC中TAM的重编程及其潜在机制。结果表明,在BC中,CTH-HS轴与TAM中抗肿瘤表型的存在呈正相关。NaHS作为HS供体,在体外和体内将TAM重新极化为M1巨噬细胞,以阻断TAM的促肿瘤活性。机制上,HS介导的蛋白质伴侣葡萄糖调节蛋白78(GRP78)的S-硫巯基化诱导内质网跨膜蛋白激酶-1α(IRE-1α)与GRP78解离,这增强了BC-TAM中IRE-1α自身的磷酸酶活性,而GRP78的Cys420位点突变干扰了这些作用。总体而言,HS在Cys420残基处介导的GRP78 S-硫巯基化通过激活IRE-1α途径对TAM进行重编程,从而降低了BC的肿瘤负担并抑制了肺转移,这表明靶向GRP78 S-硫巯基化是BC中TAM-M1重新极化的一种有前景的干预措施。